首页> 外文期刊>Trials >The acupoint herbal plaster for the prevention and treatment of postoperative nausea and vomiting after PLIF with general anesthesia: study protocol for a multicenter randomized controlled trial
【24h】

The acupoint herbal plaster for the prevention and treatment of postoperative nausea and vomiting after PLIF with general anesthesia: study protocol for a multicenter randomized controlled trial

机译:用于预防和治疗术后恶心和呕吐的穴位草本膏药与全身麻醉术后:多中心随机对照试验的研究方案

获取原文
           

摘要

Background Postoperative nausea and vomiting (PONV) are common in posterior lumbar intervertebral fusion (PLIF) patients undergoing general anesthesia. The previous clinical observation has shown that a traditional acupoint herbal plaster (AHP) is beneficial to patients with PONV. This trial aims to assess the effect of the AHP for the prevention and treatment of PONV after PLIF in patients with general anesthesia. Methods A multicenter, parallel, randomized controlled trial (RCT) will be conducted. A total of 166 participants will be randomized to either a treatment group receiving an AHP or a control groups receiving an acupoint placebo plaster (APP) in a 1:1 ratio. The primary outcomes are the first occurrence and frequency of nausea and vomiting. The secondary outcomes include the severity grading of nausea and vomiting using a visual analog scale (VAS) measurement system, quality of life, and serological indicators. The safety evaluation is mainly about adverse events and skin reactions’ observation. Assessments will be carried out at the baseline, day 1, and day 2 (the end of the intervention). The central randomization system in the clinical trial ( http://124.205.181.142:8082/xwtf/ ) will be used to conduct random allocation. Discussion This scientific methodology design of the trial is expected to provide clinical evidence to support the AHP for the prevention and treatment of PONV. Trial registration This study is retrospectively registered with the Chinese Clinical Trial Registry ( http://www.chictr.org.cn ) on 19 April 2018. ID: ChiCTR1800015768.
机译:背景技术术后恶心和呕吐(PONV)在后腰椎椎间融合(PLIF)患者中常见为全身麻醉。先前的临床观察表明,传统的穴位草药(AHP)对PONV患者有益。该试验旨在评估AHP在全身麻醉患者患者患者中预防和治疗PONV的影响。方法将进行多中心,并行,随机对照试验(RCT)。总共166名参与者将被随机分配给接受AHP的治疗组或在1:1的比例中接受ACUPoint安慰剂(APP)的对照组。主要结果是恶心和呕吐的第一次发生和频率。二次结果包括使用视觉模拟量表(VAS)测量系统,生活质量和血清学指标的恶心和呕吐的严重性分级。安全评估主要是关于不良事件和皮肤反应的观察。评估将在基线,第1天和第2天(干预结束)进行。临床试验中的中央随机化系统(http://124.205.181.142:8082/xwtf/)将用于进行随机分配。讨论这种审判的科学方法论预计将提供临床证据,以支持AHP预防和治疗PONV。试用注册本研究于2018年4月19日回顾性地注册了中国临床试验登记处(http://www.chictr.org.cn).D:Chictr1800015768。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号